The Non-alcoholic steatohepatitis (NASH) Congressional briefing co-led by The American Association for the Study of Liver Diseases (AASLD) and Global Liver Institute (GLI) focused on establishing a national strategy to advance prevention, treatment, and diagnosis of NASH, the most severe form of nonalcoholic fatty liver disease.